Literature DB >> 10837726

Delivery of contrast agents for positron emission tomography imaging by liposomes.

.   

Abstract

Liposomes encapuslating positron emitters are applicable for diagnostic imaging and are useful to investigate the real-time liposomal trafficking in vivo. Long-circulating liposomes encapsulaing [2-(18)F]-2-fluoro-2-deoxyglucose were administrated to tumor-bearing mice, and a PET scan was performed. Small-sized long-circulating liposomes (100 nm) tended to accumulate in tumor tissues of tumor-bearing mice as compared with conventional liposomes. Then the size effect on trafficking of long-circulating liposomes was investigated. Large-sized liposomes (>300 nm) accumulated in liver and spleen in a time dependent manner. On the contrary, small-sized ones (<200 nm) were transiently accumulated in the liver right after injection, but the accumulation decreased time dependently, suggesting that, although the majority of small long-circulating liposomes remain in bloodstream, some extravasate once into interstitial spaces in liver which re-enter into bloodstream again. Next the trafficking of so-called long-circulating liposomes, i.e., liposomes modified with ganglioside GM1, palmityl glucuronide (PGlcUA), and polyethylene glycol (PEG), in tumor-bearing mice was examined. The accumulation of all three kinds of long-circulating liposomes in liver decreased time-dependently, and PGlcUA-liposomes could avoid liver-trapping the most efficiently. Tumor accumulation of liposomes was obvious for PGlcUA-liposomes and PEG-liposomes from immediately after injection, but not for GM1-liposomes. Finally, the trafficking of differently charged liposomes was investigated in normal mice. The accumulation of positively charged liposomes containing 1,2-dimyristyloxypropyl-3-dimethyl-hydroxyethyl bromide was different from that of neutral and negatively charged DCP-liposomes. The agglutinability of and serum protein ginding to positively charged liposomes were marked, suggesting that these factors affect the high accumulation of DMRIE-liposomes in liver. Non-invasive PET analysis of liposomal trafficking is beneficial for obtaining information about liposomal drug delivery, and long-circulating liposomes might be useful for diagnostic tumor imaging by PET.

Entities:  

Year:  1999        PMID: 10837726     DOI: 10.1016/s0169-409x(98)00110-0

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  6 in total

1.  Integrin-targeted paclitaxel nanoliposomes for tumor therapy.

Authors:  Shuyan Meng; Bo Su; Wei Li; Yongmei Ding; Liang Tang; Wei Zhou; Yin Song; Zhou Caicun
Journal:  Med Oncol       Date:  2010-07-20       Impact factor: 3.064

2.  Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects.

Authors:  Jai Woong Seo; Lisa M Mahakian; Azadeh Kheirolomoom; Hua Zhang; Claude F Meares; Riccardo Ferdani; Carolyn J Anderson; Katherine W Ferrara
Journal:  Bioconjug Chem       Date:  2010-07-21       Impact factor: 4.774

3.  Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP).

Authors:  Jan Marik; Michaelann S Tartis; Hua Zhang; Jennifer Y Fung; Azadeh Kheirolomoom; Julie L Sutcliffe; Katherine W Ferrara
Journal:  Nucl Med Biol       Date:  2007-02       Impact factor: 2.408

4.  Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PET.

Authors:  Cecilie B Rygh; Shengping Qin; Jai W Seo; Lisa M Mahakian; Hua Zhang; Roger Adamson; Jane Q Chen; Alexander D Borowsky; Robert D Cardiff; Rolf K Reed; Fitz-Roy E Curry; Katherine W Ferrara
Journal:  Clin Cancer Res       Date:  2010-11-24       Impact factor: 12.531

Review 5.  Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy.

Authors:  Gann Ting; Chih-Hsien Chang; Hsin-Ell Wang; Te-Wei Lee
Journal:  J Biomed Biotechnol       Date:  2010-08-03

6.  Dynamic microPET imaging of ultrasound contrast agents and lipid delivery.

Authors:  Michaelann S Tartis; Dustin E Kruse; Hairong Zheng; Hua Zhang; Azadeh Kheirolomoom; Jan Marik; Katherine W Ferrara
Journal:  J Control Release       Date:  2008-07-29       Impact factor: 9.776

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.